GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK)

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / COM
Total 13F shares
232,446,713
Share change
-18,482,127
Total reported value
$9,681,481,087
Put/Call ratio
99%
Price per share
$41.65
Number of holders
708
Value change
-$828,806,005
Number of buys
329
Number of sells
291

Institutional Holders of GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) as of Q2 2015

As of 30 Jun 2015, GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) was held by 708 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 232,446,713 shares. The largest 10 holders included Dodge & Cox, ROYAL BANK OF CANADA, HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC, Fisher Asset Management, LLC, WELLS FARGO & COMPANY/MN, FMR LLC, STATE STREET CORP, JPMORGAN CHASE & CO, FEDERATED INVESTORS INC /PA/, and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 708 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.